Primary information |
---|
ID | antitb_1947 |
Peptide Name | Peptide-10 |
Sequence | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK |
N-terminal Modification | Acetylation |
C-terminal Modification | Amidation |
Chemical Modification | A5c = 1-aminocyclopentane carboxylic acid, A6c 1-aminocyclohexane carboxylic acid |
Linear/ Cyclic | Linear |
Length | 20 |
Chirality | D |
Nature | Cationic |
Source | Synthetic |
Origin | NA |
Species | Mycobacterium tuberculosis |
Strain | Mycobacterium tuberculosis XDR |
Inhibition Concentartion | MIC = 11.21 μM |
In vitro/In vivo | In vitro |
Cell Line | NA |
Inhibition Concentartion | NA |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Response | NA |
Mechanism of Action | NA |
Target | Cell wall pore formation |
Combination Therapy | NA |
Other Activities | Antibacterial against Enterobacter aerogenes, Acinetobacter baumannii, Psuedomonas aeruginosa, Klebsiella pneumoniae, Eenterococcus faecalis, Staphylococcus aureus |
Pubmed ID | 27387357 |
Year of Publication | 2016 |
3-D Structure | NA |